1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cohen & Steers reported results for the quarter ended June 30, 2025. Revenue rose 1.2% from the first quarter to $136.1 million and 11.8% from a year earlier, but operating income fell 4.1% sequentially to $43.3 million and diluted earnings per share fell 7.5% to $0.72, with operating margin down to 31.8% from 33.6%. Compared with the second quarter of 2024, diluted EPS rose 14.4% from $0.63. Assets under management ended the quarter at $88.9 billion, though the firm recorded net outflows of $131 million.
Total revenue of $136.1 million, up 1.2% from $134.5 million in the first quarter of 2025 and up 11.8% from $121.7 million a year earlier
Diluted EPS of $0.72 versus $0.77 in the first quarter; adjusted diluted EPS of $0.73 versus $0.75
Operating margin of 31.8% versus 33.6% in the first quarter; adjusted operating margin of 33.6%
Ending assets under management of $88.9 billion, up 1.5% from March 31, 2025, with net outflows of $131 million
Talen Energy said its subsidiary agreed to buy two combined-cycle gas plants, Moxie Freedom in Pennsylvania and Guernsey in Ohio, from Caithness Energy for $1.46 billion and $2.33 billion in cash, subject to adjustments. Talen said the net price after estimated tax benefits is $3.5 billion, and it expects $3.8 billion in new debt to fund the deal, with closing expected in the fourth quarter of 2025 pending regulatory approvals. The company said the deal is expected to be accretive to free cash flow per share by over 40% in 2026, but the closing depends on regulatory approvals and financing conditions.
Purchase prices: $1.46 billion for Moxie Freedom (1,105 MW) and $2.33 billion for Guernsey (1,875 MW), with cash paid at closing
Talen expects to issue about $3.8 billion of new debt; debt commitment letters cover up to $1.2 billion of senior secured and $2.57 billion of senior unsecured bridge facilities
Closing is expected in Q4 2025 and requires FERC approval and HSR waiting-period clearance
Talen plans about $500 million of annual share repurchases through the 2026 deleveraging period
SL Green reported a second-quarter 2025 net loss attributable to common stockholders of $11.1 million, or $0.16 per share, compared with a net loss of $2.2 million, or $0.04 per share, a year earlier, and FFO of $1.63 per share, down from $2.05. The company raised its 2025 FFO per share guidance to $5.65 to $5.95 while keeping its 2025 net income per share guidance at $1.27 to $1.57.
Q2 2025 net loss attributable to common stockholders was $11.1 million, or $0.16 per share, versus a net loss of $2.2 million, or $0.04 per share, in Q2 2024.
Q2 2025 FFO was $1.63 per share, down from $2.05 per share a year earlier; total revenues were $241.9 million versus $222.8 million.
2025 FFO per share guidance was revised to $5.65 to $5.95 from $5.25 to $5.55, an increase of $0.40 per share at the midpoint, while net income guidance of $1.27 to $1.57 per share was maintained.
Manhattan same-store office occupancy was 91.4% at June 30, 2025, and the company expects it to reach 93.2% by December 31, 2025.
Synopsys completed its acquisition of Ansys on July 17, 2025, with Ansys becoming a wholly owned subsidiary. Ansys shareholders received 0.3399 Synopsys shares plus $199.91 in cash per share, and Synopsys funded the cash portion partly with a $4.3 billion term loan, which adds significant debt for shareholders to weigh.
Each Ansys share converted into 0.3399 Synopsys common share and $199.91 in cash, with the exchange ratio reduced to keep share issuance within 19.9999% of outstanding Synopsys shares.
Synopsys borrowed the full $4.3 billion available under its Term Loan Credit Agreement on July 17, 2025.
Synopsys terminated about $690 million in remaining bridge facility commitments, reducing bridge commitments to $0.
Ajei Gopal and Ravi Vijayaraghavan joined the Synopsys board effective at the Effective Time, and Ansys common stock will no longer be listed on NASDAQ.
ManpowerGroup reported a second-quarter 2025 net loss of $67.1 million, or $1.44 per diluted share, compared with net earnings of $60.1 million, or $1.24 per diluted share, a year earlier. Revenue was flat at $4.5 billion, and the loss reflects an $88.7 million non-cash goodwill and intangible impairment, restructuring costs, and losses from business sales; excluding these charges, EPS was $0.78. The company also guided third-quarter diluted EPS to $0.77 to $0.87.
Q2 2025 revenue was $4.5 billion, flat from the prior year period (down 3% in constant currency).
Net loss was $67.1 million versus net earnings of $60.1 million a year earlier; diluted EPS was -$1.44 versus $1.24.
Non-cash impairment charges were $88.7 million, mainly tied to the Switzerland and U.K. businesses.
Third-quarter 2025 diluted EPS guidance is $0.77 to $0.87.
Elevance Health reported second quarter 2025 operating revenue of $49.4 billion, up 14.3% from a year earlier, but diluted EPS fell to $7.72 from $9.85 and adjusted diluted EPS fell to $8.84 from $10.30. The company revised its full-year 2025 adjusted diluted EPS guidance to approximately $30.00 and projected GAAP diluted EPS of approximately $24.10, citing elevated medical cost trends in ACA and slower rate alignment in Medicaid. Shareholders face lower profit expectations even as sales grew.
Q2 2025 operating revenue $49.4 billion, up 14.3%; benefit expense ratio rose to 88.9% from 86.3% in the prior-year quarter
Q2 2025 diluted EPS $7.72 vs. $9.85 a year earlier; adjusted diluted EPS $8.84 vs. $10.30
2025 adjusted diluted EPS outlook revised to approximately $30.00; GAAP diluted EPS outlook approximately $24.10
Returned $2.0 billion to shareholders year-to-date; third quarter dividend of $1.71 per share payable September 25, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.